Effect of combining ACE inhibitor and statin in severe experimental nephropathy
- 1 May 2002
- journal article
- Published by Elsevier BV in Kidney International
- Vol. 61 (5), 1635-1645
- https://doi.org/10.1046/j.1523-1755.2002.00332.x
Abstract
No abstract availableThis publication has 40 references indexed in Scilit:
- Tubulointerstitial renal diseaseCurrent Opinion in Nephrology and Hypertension, 2001
- Protein traffic activates NF-kB gene signaling and promotes MCP-1–dependent interstitial inflammationAmerican Journal of Kidney Diseases, 2000
- Nephropathic nature of proteinuriaCurrent Opinion in Nephrology and Hypertension, 1999
- Induction of Monocyte Chemoattractant Protein-1 by Albumin Is Mediated by Nuclear Factor κB in Proximal Tubule CellsJournal of the American Society of Nephrology, 1999
- Pathophysiology of Progressive NephropathiesThe New England Journal of Medicine, 1998
- Protein overload stimulates RANTES production by proximal tubular cells depending on NF-kB activationKidney International, 1998
- The renoprotective properties of angiotensin-converting enzyme inhibitors in a chronic model of membranous nephropathy are solely due to the inhibition of angiotensin II: Evidence based on comparative studies with a receptor antagonistAmerican Journal of Kidney Diseases, 1997
- Lipids and the kidneyKidney International, 1994
- Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat.JCI Insight, 1986
- Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension.JCI Insight, 1986